[144] MEI Pharma, Inc. SEC Filing

Rhea-AI Filing Summary

MEI Pharma, Inc. (MEIP) – Form 144 filing

A holder has notified intent to sell up to 611,440 common shares through TD Securities (USA) LLC, targeting 23 Jul 2025. The proposed block carries an aggregate market value of US$3.79 million, implying a price near US$6.20 per share. The shares equal roughly 2.0 % of MEI Pharma’s 29.88 million shares outstanding.

The seller purchased the shares for cash in an open-market transaction on 15 Mar 2023 and reports no other sales in the past three months. By signing, the filer affirms possession of no undisclosed adverse information.

Insights

Securities Analyst

TL;DR: 611k-share Form 144 (~2% float) is a modest supply overhang and mildly negative.

The filing signals a potential insider or large shareholder exit of US$3.8 million worth of stock. While 2 % of outstanding shares is not outsized, it can pressure a small-cap name like MEIP if executed quickly, particularly given limited liquidity. Absence of other recent sales and the fact that shares were bought on the open market in 2023 temper concerns, but investors often view Form 144 activity as a short-term bearish indicator.

Portfolio Manager

TL;DR: Sale intention is minor relative to float; impact depends on trading volume.

At ~US$3.8 million, the block equals one to two days of average volume for many micro-caps, so market impact may be transient if the broker stages the sale. Lack of disclosed relationship makes motive unclear. Still, monitoring execution and any additional filings is prudent before adjusting position sizing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	TD Securities (USA) LLC One Vanderbilt Ave New York NY 10017	611440	3790928.00	29879755	07/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/15/2023	Open Market Purchase(1)	Open Market Purchase(1)			611440	03/15/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many MEIP shares are being sold under this Form 144?

The notice covers 611,440 common shares.

What is the aggregate market value of the proposed MEIP sale?

The filer lists an aggregate value of US$3.79 million.

When is the approximate sale date for the MEIP shares?

The filer indicates an approximate sale date of 23 July 2025.

What percentage of MEI Pharma’s outstanding shares does the block represent?

The 611,440 shares equal roughly 2 % of the 29.88 million shares outstanding.

Where will the MEIP shares be sold?

The shares are slated for sale on the NASDAQ via TD Securities (USA) LLC.